RTSM Resources

  1. RTSM And Clinical Drug Dispensation 7/16/2024

    A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.

  2. Bringing RTSM In From The Cold 11/2/2023

    Watch James Stringer's presentation from the October 2023 Clinical Leader Solutions Expo: IRT Showcase to learn how site burden can be reduced by having more consolidated platforms.

  3. The Present And Future Of Study Supply Management 6/17/2024

    Gain expert insights on the future of RTSM strategy and its evolution with the changing clinical supply and technology landscape in our webinar.

  4. Empowering Oncology Research With The Right Technology Solutions 10/25/2023

    Explore how advanced technology solutions have the potential to simplify the operational aspects of oncology trials.

  5. Simplify Clinical Trials With Signant SmartSignals® Unified Platform 8/16/2024

    Signant SmartSignals® Unified Platform streamlines clinical trials by integrating eConsent, data collection, remote consultations, and randomization, simplifying workflows for patients and site staff.

  6. Top 5 Reasons You Need IRT Expertise (Not Just Software) 7/11/2022

    Gain insight into why pharma companies generally seek IRT vendor relationships to ensure high-quality builds that meet their needs and avoid the potential pitfalls associated with RTSM.

  7. Why Data Integrity Still Matters — Even As Clinical Trials Evolve 12/4/2025

    Data integrity remains essential for compliance and patient safety. Learn strategies to maintain accuracy and reliability as clinical research evolves toward more connected, technology-driven models.

  8. RTSM/IRT In Clinical Trials: The Complete Guide 1/27/2025

    RTSM/IRT systems are essential to modern clinical trials. This guide explores how to implement and optimize them to boost efficiency, streamline operations, uphold study integrity, and ensure compliance.

  9. Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial 1/16/2024

    Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.

  10. Master Protocols: Implementing Effective Treatment Adaptations 8/25/2025

    From balancing treatment ratios and managing eligibility to accommodating site-specific readiness and protocol amendments, a well-designed IRT system enables seamless transitions.